CytoSorbents reiterates Q4 product revenue view $9M-$9.2M

Full-year product revenue in the range of $35.4 million to $35.6 million, representing approximately 14% growth versus $31.1 million for the full-year 2023. Fourth quarter product gross margin of approximately 70%, compared to 61% in the prior quarter and 72% in the fourth quarter of 2023